Serial #78144228
DEAD

Serial Number

78144228

Owner

KARO BIO AB

Attorney

Mainak H. Mehta

Filing Date

Jul 16, 2002

Add to watchlist:

No watchlists yet
View on USPTO

Serial #78144228 Trademark

Serial Number: 78144228 • Registration: 3311631

Serial #78144228 is a trademark filed by KARO BIO AB on July 16, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 14 (Jewelry), Class 16 (Paper Goods), Class 25 (Clothing). The application is currently no longer active.

Owner Contact Info

KARO BIO AB (8 trademarks)

57 HUDDINGE
NOVUM, S-141 , SE

Entity Type: 03

Trademark Details

Filing Date

July 16, 2002

Registration Date

October 16, 2007

Published for Opposition

July 31, 2007

Cancellation Date

May 18, 2018

Goods & Services

[ Pharmaceutical preparations for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; pharmaceutical substances, namely, dermatological creams for the treatment of skin disorders; veterinary preparations for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; veterinary substances, namely, dermatological creams for use in the treatment of skin disorders, medicinal preparations for the treatment of metabolic disorders such as such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; medicinal substances, namely, dermatological cream for the treatment of skin disorders; medical diagnostic reagents; diagnostic agents for veterinary use; clinical medical reagents, namely, reagents for clinical-chemical tests; diagnostic reagents for clinical or medical laboratory use; vaccines; transdermal drug patches sold with medication for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, stroke, peripheral vascular disease, thromboembolism, retenosis of catheterization or surgical repairs, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections ]

Publications and printed matter, namely, magazines, brochures and literature pertaining to drug research; stationery; pens, pencils, notebook binders and business cards

[ Jewelry; watches; clocks; and key rings made of precious metal ]

Clothing namely, t-shirts, jumpers, fleece sweaters, jackets, caps and socks, footwear, head wear; and waterproof clothing, namely, t-shirts, jumpers, fleece sweaters, jackets, caps and socks, footwear, head wear

[ Chemical reagents for scientific or research use, namely, assays for identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, assays for the identification of the biological activity of biologically active substances, such as enzymes or receptors, assays for the identification of antibacterial compounds, compounds capable of modulating the biological activity of a biologically active substance, such as an enzyme or a receptor, and tissue culture growth media; chemical preparations for use in medical research, namely, reagents for the identification of compounds that bind and/modulate one or more biologically active substances, such as receptors and enzymes, assays for the identification of the biological activity of biologically active substances such as enzymes or receptors; assays for the identification of antibacterial compounds, compounds capable of modulating the biological activity of a biologically active substance, such as an enzyme or receptor; biochemicals for industrial purposes, namely, tissue culture growth media; chemical and biological substances for use in the manufacture of medicinal, pharmaceutical and veterinary products ]

Pharmaceutical advice services and provision of medical information

[ Diagnostic kits for medical and veterinary purposes comprised of diagnostic apparatus for medical and veterinary purposes, namely, apparatus used in identifying compounds that bind and/or modulate one or more biologically active substances, and assays and reagents for the identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, for the identification of the biological activity of biologically active substances, such as enzymes and receptors and to identify antibacterial compounds; diagnostic apparatus for medical and veterinary purposes, namely, apparatus used in identifying compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, for the identification of the biological activity of biologically active substances, such as receptors and enzymes, and to identify antibacterial compounds ]

Pharmaceutical research services; scientific research project management; scientific and industrial research; medical laboratory services; medical research; veterinary laboratory services

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
May 18, 2018 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Oct 16, 2016 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Apr 22, 2014 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 22, 2014 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 22, 2014 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Apr 8, 2014 815F
TEAS SECTION 8 & 15 RECEIVED
Apr 8, 2014 E815
REGISTERED-PRINCIPAL REGISTER
Oct 16, 2007 R.PR
PUBLISHED FOR OPPOSITION
Jul 31, 2007 PUBO
NOTICE OF PUBLICATION
Jul 11, 2007 NPUB
ELECTRONIC RECORD REVIEW COMPLETE
Jun 26, 2007 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 15, 2007 ERRR
ATTORNEY REVIEW COMPLETED
Jun 13, 2007 ATRV
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Jun 13, 2007 ATRQ
1(B) BASIS DELETED; NEW BASIS APPROVED
Jun 13, 2007 NEWR
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Jun 7, 2007 PCBG
ASSIGNED TO PETITION STAFF
Jun 5, 2007 APET
NOTICE OF ALLOWANCE CANCELLED
May 22, 2007 IUCN
PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
May 22, 2007 PDCB
PAPER RECEIVED
May 22, 2007 MAIL
SOU EXTENSION 5 GRANTED
Jan 19, 2007 EX5G
SOU EXTENSION 5 FILED
Nov 29, 2006 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 29, 2006 EEXT
SOU EXTENSION 4 GRANTED
Jun 27, 2006 EX4G
SOU EXTENSION 4 FILED
Jun 15, 2006 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 12, 2006 EEXT
ASSIGNED TO EXAMINER
Feb 14, 2006 DOCK
SOU EXTENSION 3 GRANTED
Jan 9, 2006 EX3G
SOU EXTENSION 3 FILED
Dec 7, 2005 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 7, 2005 EEXT
SOU EXTENSION 2 GRANTED
Jun 20, 2005 EX2G
SOU EXTENSION 2 FILED
Jun 13, 2005 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 13, 2005 EEXT
SOU EXTENSION 1 GRANTED
Dec 16, 2004 EX1G
SOU EXTENSION 1 FILED
Dec 6, 2004 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 6, 2004 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 15, 2004 NOAM
PUBLISHED FOR OPPOSITION
Mar 23, 2004 PUBO
NOTICE OF PUBLICATION
Mar 3, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2004 CNSA
EMAIL RECEIVED
Dec 15, 2003 EMRV
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 12, 2003 CRFA
NON-FINAL ACTION E-MAILED
Oct 30, 2003 GNRT
CASE FILE IN TICRS
Jun 23, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2003 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2003 CRFA
NON-FINAL ACTION MAILED
Nov 26, 2002 CNRT
ASSIGNED TO EXAMINER
Nov 18, 2002 DOCK
ASSIGNED TO EXAMINER
Nov 14, 2002 DOCK